Mitochondria-targeted antioxidant SkQR1 ameliorates gentamycin-induced renal failure and hearing loss

Biochemistry (Mosc). 2012 Jun;77(6):666-70. doi: 10.1134/S0006297912060144.

Abstract

The influence of the mitochondria-targeted antioxidant SkQR1 on gentamycin-induced nephrotoxicity and ototoxicity has been analyzed. SkQR1 reduces the death of kidney epithelium cells and decreases the severity of renal failure caused by gentamycin application and also lowers the animals' mortality. Treatment with SkQR1 also decreases gentamycin-induced hearing loss. Mitochondria-targeted antioxidants, such as SkQR1, are new promising agents for preventing negative consequences of therapy with antibiotics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / therapeutic use*
  • Gentamicins / adverse effects
  • Hearing Loss / chemically induced
  • Hearing Loss / prevention & control*
  • Humans
  • Kidney / drug effects
  • Kidney / pathology
  • Male
  • Mitochondria / drug effects
  • Mitochondria / metabolism
  • Organ of Corti / drug effects
  • Organ of Corti / pathology
  • Oxidative Stress / drug effects
  • Plastoquinone / administration & dosage
  • Plastoquinone / analogs & derivatives*
  • Rats
  • Renal Insufficiency / chemically induced
  • Renal Insufficiency / mortality
  • Renal Insufficiency / prevention & control*
  • Rhodamines / administration & dosage*

Substances

  • 10-(6'-plastoquinonyl) decylrhodamine 19
  • Antioxidants
  • Gentamicins
  • Rhodamines
  • Plastoquinone